Neogen Corporation
NASDAQ:NEOGMedical - Diagnostics & Research
+$0.16 today
- Market cap
- $2.42B
- Beta
- 1.80
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$2.80
Volume 1.79M
Average 2.53M
NEOG Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Neogen CorporationNASDAQ: NEOG
Common Stock · Q1 FY2027 · quarter ended Aug 2026
Common stock broadly unchanged from a year ago
Common stock stood at $34.9M at the end of Q1 FY2027, up 0.4% from a year earlier and up 0.3% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.
Context
- Common stock amounted to 1.1% of total assets at the end of Q1 FY2027, unchanged from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2026
- 34.8M USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- +19.2%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-31 | 34.8M | +0.2% |
| FY2025 | 2025-05-31 | 34.73M | +0.2% |
| FY2024 | 2024-05-31 | 34.66M | +0.2% |
| FY2023 | 2023-05-31 | 34.6M | +100.6% |
| FY2022 | 2022-05-31 | 17.25M | — |
Common Stock vs competitors
How NEOG compares with its peers on the latest reported figures
- NEOG's Aug 2026 common stock of $34.9M is the 2nd highest of the 7 companies compared; the peer median is $3.56M.
- Its year-over-year change of +0.4% is the 2nd highest of 6, against a peer median of +0.0%.
- Common stock amounts to 1.1% of total assets for NEOG, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.79B | +0.0% | +0.0% | 1.4% | |
| Aug 2026 | $34.9M | +0.4% | +0.2% | 1.1% | |
| Sep 2026 | $10.88M | +0.5% | +0.4% | 0.3% | |
| Jun 2026 | $5M | +0.0% | +0.0% | 0.0% | |
| Sep 2026 | $2.12M | -1.7% | -0.1% | 0.1% | |
| Mar 2026 | $4K | +0.0% | +0.0% | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NEOG) | $3.56M | +0.0% | +0.0% | 0.1% | |
Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 44.47M | 163.24M | 170.61M | 129M | 185.5M |
| Short-term Investments | 336.58M | 82.33M | 325K | 0 | 0 |
| Net Receivables | 99.67M | 153.25M | 173.01M | 153.38M | 146.8M |
| Inventory | 122.31M | 133.81M | 189.27M | 190.86M | 144.3M |
| Other Current Assets | 0 | 53.3M | 56.03M | 103.69M | 128M |
| Total Current Assets | 626.8M | 585.93M | 589.23M | 576.94M | 604.6M |
| Property, Plant & Equipment (Net) | 110.58M | 198.75M | 291.89M | 356.28M | 497M |
| Goodwill | 142.7M | 2.14B | 2.14B | 1.06B | 1.05B |
| Intangible Assets | 107.5M | 1.61B | 1.51B | 1.41B | 1.32B |
| Long-term Investments | 0 | 0 | 229K | 0 | 0 |
| Tax Assets | 6.93M | 19.39M | 0 | 0 | 0 |
| Other Non-current Assets | (1.59M) | 7.77M | 20.2M | 35.23M | (120.8M) |
| Total Non-current Assets | 366.13M | 3.97B | 3.96B | 2.87B | 2.74B |
| Total Assets | 992.93M | 4.55B | 4.55B | 3.44B | 3.35B |
| Account Payables | 34.61M | 76.67M | 83.06M | 79.61M | 79.1M |
| Short-term Debt | 0 | 0 | 2.45M | 19.3M | 0 |
| Tax Payables | 2.13M | 6.95M | 10.45M | 5.6M | 7.2M |
| Deferred Revenue | 5.46M | 4.62M | 4.63M | 5.56M | 3.6M |
| Other Current Liabilities | 11.12M | 28.81M | 26.24M | 44.8M | 57.3M |
| Total Current Liabilities | 77.84M | 145.47M | 154.32M | 174.01M | 158.2M |
| Long-term Debt | 0 | 885.44M | 888.39M | 874.81M | 793.7M |
| Deferred Tax Liabilities | 17.01M | 353.43M | 326.72M | 280.91M | 257.6M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 10.7M | 27.07M | 24.96M | 29.99M | 43.6M |
| Total Non-current Liabilities | 27.71M | 1.27B | 1.25B | 1.2B | 1.09B |
| Total Liabilities | 105.56M | 1.42B | 1.4B | 1.37B | 1.25B |
| Common Stock | 17.25M | 34.6M | 34.66M | 34.73M | 34.8M |
| Retained Earnings | 587.91M | 565.04M | 555.62M | (536.42M) | (544.3M) |
| Accumulated OCI | (27.77M) | (33.25M) | (30.02M) | (28.9M) | (13.6M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 2.62B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 887.37M | 3.13B | 3.14B | 2.07B | 2.09B |
| Total Debt | 0 | 897.53M | 906.24M | 912.61M | 793.7M |
| Net Debt | (44.47M) | 734.29M | 735.63M | 783.61M | 608.2M |
Neogen Corporation
NASDAQ:NEOG
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.